NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/02/2026
Back to search
Official data from USPTO
HYDRALIVE THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
03/03/2026
Trademark type
Combined
Nice classes
44
Filing date
04/22/2020
Registration date
11/10/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
07/31/2017
First use in commerce
07/31/2017
Drawing code
3
Owner type
16
Owner location
Canton, GA, US
Examiner
OAKES, ANNA JENNIE
Current location
Historical data usage
Mark description
The mark consists of a light blue liquid droplet design having a dark blue border and a dark blue heartbeat graph within the droplet, the design next to the word "HYDRALIVE" in dark blue with the "IV" in the word being in light blue, above the word "THERAPY" in light blue.
Holders and representatives
Holders
Hydralive Holdings LLC
Representatives
Laurence P. Colton SMITH TEMPEL BLAHA LLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical serviceshydration therapy through intravenous delivery of fluidsappropriate medicationsessential vitamins; intravenous hangover alleviation therapy
Publications
History of USPTO decisions and trademark events.
21 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/02/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/02/2026
E815
TEAS SECTION 8 & 15 RECEIVED
11/25/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/10/2020
DOCK
ASSIGNED TO EXAMINER
08/31/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/25/2020
PUBO
PUBLISHED FOR OPPOSITION
08/25/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/19/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2020
GNRT
NON-FINAL ACTION E-MAILED
07/17/2020
CNRT
NON-FINAL ACTION WRITTEN
07/17/2020
DOCK
ASSIGNED TO EXAMINER
07/15/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/30/2020
NWAP
NEW APPLICATION ENTERED
04/25/2020
Continuous trademark protection
Get notified about every new filing that threatens HYDRALIVE THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.